Ogatis, Gracenil Joy .
HRN: 18-26-49 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/03/2026
CEFTAZIDIME 1GM (VIAL)
06/03/2026
06/10/2026
IV
2G
Q8HRS
PERIORBITAL CELLULITIS
Checking Final Appropriateness
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes